Table 2.
Patient characteristics stratified based on TRT duration (n = 197)
Variables | Short TRT | Long TRT | P valuea | ||
---|---|---|---|---|---|
No. | % | No. | % | ||
Age (y) | |||||
≤53 | 77 | 63.11 | 29 | 38.67 | .001b |
>53 | 45 | 36.89 | 46 | 61.33 | |
Gender | |||||
Male | 105 | 86.07 | 67 | 89.33 | .660 |
Female | 17 | 13.93 | 8 | 10.67 | |
Smoking | |||||
Current/ever | 89 | 72.95 | 55 | 73.33 | 1.000 |
Never | 33 | 27.05 | 20 | 26.67 | |
Comorbidity score | |||||
=0 | 99 | 81.15 | 63 | 84.00 | .703 |
≥1 | 23 | 18.85 | 12 | 16.00 | |
Chemotherapy regimen | |||||
EP | 105 | 49.30 | 67 | 89.33 | 1.000 |
Others | 108 | 50.70 | 8 | 10.67 | |
RT fractionation | |||||
Once daily | 35 | 28.69 | 36 | 48.00 | .009b |
Twice daily | 87 | 71.31 | 39 | 52.00 | |
Albumin | |||||
Relatively low | 59 | 48.36 | 37 | 49.33 | 1.000 |
Relatively high | 63 | 51.64 | 38 |
EP, etoposide‐platinum; RT, radiotherapy; TRT, thoracic radiotherapy.
Log‐rank test.
Statistically significant.